Ovation Secures $5M Series A to Advance Cloud-Based Clinical Data Platform for Molecular Diagnostics Labs

VCBeat (WeChat ID: vcbeat) has learned that clinical data company Ovation recently announced the completion of a $5 million Series A financing round. The round was led by Madrona Venture Group, with participation from Borealis Ventures, Nat Turner, and Zach Weinberg. Including its seed round in 2015 and angel round in 2018, Ovation has raised a total of $8.7 million to date.

Ovation is a scientific data company that provides cloud-based laboratory information management systems (LIMS) for molecular diagnostics laboratories. In addition to standard sample and workflow tracking, Ovation addresses key functional areas such as relationship support, laboratory operations, and business analytics. Leveraging modern infrastructure and assembling top-tier partners and consultants, Ovation offers scalable, user-friendly laboratory management systems tailored to the specific needs of each laboratory.

The company will leverage this funding to accelerate laboratory deployment and expand its capabilities, enabling independent laboratories to effectively grow their businesses and maximize business value from data. The LIMS offers functionalities for laboratory workflow management, sample tracking, archive management, personnel training, and external portals, as well as an ecosystem supporting revenue cycle management, clinical interpretation, consulting services, and business analytics. All these features rely on extensive clinical data hosted on a cloud-based platform.

Schematic Diagram of the Management System (Image Source: Ovation Official Website)

“Support for Ovation demonstrates that investors are keen on novel approaches to leveraging laboratory data, which can help them grow their businesses and fully capitalize on existing data assets. LIMS plays a crucial role in patient diagnosis and treatment, while also accelerating the development of new therapies. We are delighted to partner with these investors and appreciate their support for the growth of diagnostic laboratories,” said Barry Wark, Co-Founder and CEO.

Barry Wark studied at Stanford University and the University of Washington, holding a Ph.D. in Neurobiology and Behavior. Four members of the founding team are also scientists in the medical field, possessing specialized academic knowledge and extensive experience.

Madrona Venture Group is a Seattle-based venture capital firm founded in 1995. The company primarily invests in early-stage startups in the information technology sector, with investment focuses including consumer internet, enterprise software and services, digital media, and advertising. Madrona currently manages nearly $100 million in assets, with successful investments including Amazon.com, Farecast, Isilon Systems, Conclude, and World Wide Packets.

Borealis Ventures, headquartered in New Hampshire, USA, focuses on early-stage venture capital investments in the information technology and life sciences sectors. Its investment portfolio spans areas such as 3D design, construction management, and data-driven software, with a total of 45 companies invested in to date.

(Compiled by Yang Shaobo)